Agenda

FRIDAY, AUG. 14 Moderator: Sobia Laique, MD All times in Eastern Time
SESSION 1: MASLD/MASH – Burden,Diagnosis, and Clinical Implications
7:00–8:00 AM	Breakfast / Exhibits
8:00–8:10 AM	Introduction to the Course Sobia Laique, MD
8:10–8:30 AM	The Global Burden of MASLD: Epidemiology, Outcomes, and Health System Impact Zobair Younossi, MD
8:30–8:50 AM	Screening, Risk Stratification, and Surveillance: Who Are We Missing? Meena Bansal, MD
8:50–9:10 AM	Histopathology of MASH: What Still Requires Tissue, and Why It Matters Daniela Allende, MD
9:10–9:30 AM	The Growing Burden of MASH Cirrhosis: Clinical Outcomes and Transplantation
9:30–10:00 AM	Panel Discussion: From Population Risk to Cirrhosis: Where Are We Falling Short in MASLD/MASH Care? Moderator: Sobia Laique, MD Panelists: Daniela Allende, MD; Meena Bansal, MD; Zobair Younossi, MD
10:00–10:30 AM	Break / Exhibits
SESSION 2: Treatment of MASH Across the Disease Spectrum
10:30–10:50 AM	Incretin Therapy in MASH: Semaglutide and Related Agents Keren Zhou, MD
10:50–11:10 AM	Disease-Modifying Therapy in MASH: Resmetirom and Emerging Strategies Across Fibrosis and Cirrhosis Naim Alkhouri, MD
11:10–11:30 AM	Metabolic and Bariatric Surgery in MASH Ali Aminian, MD
11:30–11:50 AM	Delivering MASH Care at Scale: The Multidisciplinary MASLD Clinic Model Sobia Laique, MD
11:50 AM–12:10 PM	Cardio-Renal-Metabolic Risk in MASH Luke Laffin, MD
12:10–12:30 PM	Sarcopenia and Frailty in MASH: Clinical Relevance and Management Considerations Srinivasan Dasarathy, MD
12:30–1:00 PM	Panel Discussion: Precision Treatment in MASH: Matching Therapies to Patient Phenotypes Moderator: Zobair Younossi, MD Panelists: Naim Alkhouri, MD; Ali Aminian, MD; Srinivasan Dasarathy, MD; Luke Laffin, MD; Sobia Laique, MD; Keren Zhou, MD
1:00–2:00 PM	Lunch / Exhibits
SESSION 3: Translational Science and Clinical Research in MASH
2:00–2:20 PM	Computational Approaches to MASH Pathophysiology and Drug Discovery
2:20–2:40 PM	Artificial Intelligence in MASH and Transplant Research: Risk Prediction, Drug Development, and Trial Design Chase Wehrle, MD
2:40–3:00 PM	Clinical Trial Design in MASH: Endpoints, Populations, and Evolving Regulatory Expectations Naim Alkhouri, MD
3:00–3:20 PM	Studying MASH in Cirrhosis: Pathobiology, Endpoints, and Research Challenges Mary Rinella, MD
3:20–3:40 PM	Big Data and Transplantation: A New Age of Donor Assessment and Management Kazunari Sasaki, MD
3:40–4:00 PM	Panel Discussion: The Future of MASH Research Moderator: Sobia Laique, MD Panelists: Naim Alkhouri, MD; Mary Rinella, MD; Kazunari Sasaki, MD; Chase Wehrle, MD
4:00 PM	Adjourn
4:30–6:30 PM	Networking Reception (Non-CME/Optional)

SATURDAY, AUG. 15 Moderator: Ali Aminian, MD All times in Eastern Time
SESSION 4A: Transplant Candidacy, Risk Stratification, and Outcomes in MASH
7:00–7:45 AM	Breakfast / Exhibits
7:45–8:00 AM	Welcome Ali Aminian, MD
8:00–8:20 AM	Beyond MELD: Transplant Evaluation and Risk Stratification in MASH Cirrhosis
8:20–8:40 AM	Acute on Chronic Liver Failure in MASH: Prognosis, Optimization, Transplant Timing Christina Lindenmeyer, MD
8:40–9:00 AM	Cardiac Risk Assessment in the MASH Transplant Candidate Maan Fares, MD
9:00–9:20 AM	Metabolic Surgery and Liver Transplantation Matthew Kroh, MD
9:20–9:40 AM	The Role of Living Donor Liver Transplantation in MASH Julie Heimbach, MD
9:40–10:00 AM	Panel Discussion: Optimizing Transplant Candidacy and Outcomes in MASH Moderators: Ali Aminian, MD and Koji Hashimoto, MD, PhD Panelists: Maan Fares, MD; Julie Heimbach, MD; Matthew Kroh, MD
10:00–10:30 AM	Break / Exhibits
SESSION 4B: Complex and Multi-Organ Transplant Decision-Making in MASH
10:30–10:50 AM	Liver Kidney Transplantation in MASH: Selection Criteria, Outcomes, and Allocation Kazunari Sasaki, MD
10:50–11:10 AM	Modern Multi-Organ Transplant: Heart-Lung-Liver Kenneth McCurry, MD
11:10–11:30 AM	Organ Preservation Strategies in High-Risk Liver Transplantation: Clinical Decision-Making Andrea Schlegel, MD
11:30–11:50 AM	Robotic and Minimally Invasive Liver Transplantation: Current Indications and Outcomes Alejandro Pita, MD
11:50 AM–12:00 PM	Panel Questions Moderator: Koji Hashimoto, MD, PhD Panelists: Kenneth McCurry, MD; Alejandro Pita, MD; Kazunari Sasaki, MD; Andrea Schlegel, MD
12:00–1:00 PM	Lunch / Exhibits
SESSION 5: MASH and Cancer (HCC, CCA)
1:00–1:20 PM	Early Diagnosis, Staging, and Management of MASH Related Cancers: Hepatocellular Carcinoma and Cholangiocarcinoma Shilpa Junna, MD
1:20–1:40 PM	Locoregional and Systemic Treatment Approaches for Liver Cancer Suneel Kamath, MD
1:40–2:00 PM	Patient Selection for Liver Transplantation in MASH-Associated Liver Cancer
2:00–2:20 PM	Panel Discussion: Multidisciplinary Decision-Making in MASH-Associated Liver Cancer Moderators: Mazhar Khalil, MD and Federico Aucejo, MD Panelists: Julie Heimbach, MD; Shilpa Junna, MD; Suneel Kamath, MD
2:20 PM	Adjourn
NON-CME SESSION: HANDS ON SYMPOSIUM
2:45–4:15 PM	Breakout 1: Machine Perfusion in Liver Transplantation: HOPE, Normothermic Perfusion, and Regional Perfusion Andrea Schlegel, MD; Koji Hashimoto, MD, PhD; Chase Wehrle, MD Breakout 2: Hands-On Fibrosis Assessment and Shared Medical Appointments in MASH Sobia Laique, MD; Keren Zhou, MD Breakout 3: Bariatric and Metabolic Surgery in Patients with Liver Disease: Patient Selection and Pathways Ali Aminian, MD; Salvador Navarrete, MD Breakout 4: Hands-On Minimally Invasive and Non-Invasive Therapies for Liver Tumors: Robotic Resection and Histotripsy Mazhar Khalil, MD; Federico Aucejo, MD; Alejandro Pita, MD; Jaekeun Kim, MD
4:30–5:30 PM	Networking Reception (Non-CME/Optional)

Agenda

FRIDAY, AUG. 14
Moderator: Sobia Laique, MD
All times in Eastern Time

SESSION 1:
MASLD/MASH – Burden,Diagnosis, and Clinical Implications

SESSION 2:
Treatment of MASH Across the Disease Spectrum

SESSION 3:
Translational Science and Clinical Research in MASH

SATURDAY, AUG. 15
Moderator: Ali Aminian, MD
All times in Eastern Time

SESSION 4A:
Transplant Candidacy, Risk Stratification, and Outcomes in MASH

SESSION 4B:
Complex and Multi-Organ Transplant Decision-Making in MASH

SESSION 5:
MASH and Cancer (HCC, CCA)

NON-CME SESSION:
HANDS ON SYMPOSIUM

Agenda

FRIDAY, AUG. 14 Moderator: Sobia Laique, MD All times in Eastern Time

SESSION 1:MASLD/MASH – Burden,Diagnosis, and Clinical Implications

SESSION 2:Treatment of MASH Across the Disease Spectrum

SESSION 3: Translational Science and Clinical Research in MASH

SATURDAY, AUG. 15 Moderator: Ali Aminian, MD All times in Eastern Time

SESSION 4A:Transplant Candidacy, Risk Stratification, and Outcomes in MASH

SESSION 4B: Complex and Multi-Organ Transplant Decision-Making in MASH

SESSION 5:MASH and Cancer (HCC, CCA)

NON-CME SESSION: HANDS ON SYMPOSIUM

FRIDAY, AUG. 14
Moderator: Sobia Laique, MD
All times in Eastern Time

SESSION 1:
MASLD/MASH – Burden,Diagnosis, and Clinical Implications

SESSION 2:
Treatment of MASH Across the Disease Spectrum

SESSION 3:
Translational Science and Clinical Research in MASH

SATURDAY, AUG. 15
Moderator: Ali Aminian, MD
All times in Eastern Time

SESSION 4A:
Transplant Candidacy, Risk Stratification, and Outcomes in MASH

SESSION 4B:
Complex and Multi-Organ Transplant Decision-Making in MASH

SESSION 5:
MASH and Cancer (HCC, CCA)

NON-CME SESSION:
HANDS ON SYMPOSIUM